SE393111B - Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin - Google Patents

Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin

Info

Publication number
SE393111B
SE393111B SE7309781A SE7309781A SE393111B SE 393111 B SE393111 B SE 393111B SE 7309781 A SE7309781 A SE 7309781A SE 7309781 A SE7309781 A SE 7309781A SE 393111 B SE393111 B SE 393111B
Authority
SE
Sweden
Prior art keywords
ergoline
halogen
substituted
methyl
procedure
Prior art date
Application number
SE7309781A
Other languages
English (en)
Swedish (sv)
Inventor
J A Clemens
E C Kornfeld
N J Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE393111B publication Critical patent/SE393111B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7309781A 1972-07-21 1973-07-12 Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin SE393111B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27390272A 1972-07-21 1972-07-21

Publications (1)

Publication Number Publication Date
SE393111B true SE393111B (sv) 1977-05-02

Family

ID=23045910

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7309781A SE393111B (sv) 1972-07-21 1973-07-12 Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE7611467A SE410603B (sv) 1972-07-21 1976-10-15 Forfarande for framstellning av d-2,6-dimetyl-8-cyano- eller 8-karboxamido-metylergolin
SE7611466A SE410459B (sv) 1972-07-21 1976-10-15 Mellanforening till anvendning vid framstellning av en d-2-substituerad-6-metyl-8-substituerad ergolin

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE7611467A SE410603B (sv) 1972-07-21 1976-10-15 Forfarande for framstellning av d-2,6-dimetyl-8-cyano- eller 8-karboxamido-metylergolin
SE7611466A SE410459B (sv) 1972-07-21 1976-10-15 Mellanforening till anvendning vid framstellning av en d-2-substituerad-6-metyl-8-substituerad ergolin

Country Status (24)

Country Link
JP (2) JPS576431B2 (US06373033-20020416-M00071.png)
AR (3) AR206772A1 (US06373033-20020416-M00071.png)
AT (1) AT331425B (US06373033-20020416-M00071.png)
BE (1) BE802531A (US06373033-20020416-M00071.png)
BG (3) BG21410A3 (US06373033-20020416-M00071.png)
CA (1) CA1006159A (US06373033-20020416-M00071.png)
CH (5) CH581135A5 (US06373033-20020416-M00071.png)
CS (1) CS208164B2 (US06373033-20020416-M00071.png)
DD (1) DD107690A5 (US06373033-20020416-M00071.png)
DE (2) DE2335750C3 (US06373033-20020416-M00071.png)
DK (1) DK140986B (US06373033-20020416-M00071.png)
ES (5) ES417078A1 (US06373033-20020416-M00071.png)
FR (1) FR2193606B1 (US06373033-20020416-M00071.png)
GB (1) GB1423065A (US06373033-20020416-M00071.png)
HU (1) HU167274B (US06373033-20020416-M00071.png)
IE (1) IE37936B1 (US06373033-20020416-M00071.png)
IL (3) IL42730A (US06373033-20020416-M00071.png)
NL (1) NL7309969A (US06373033-20020416-M00071.png)
PH (1) PH11229A (US06373033-20020416-M00071.png)
RO (2) RO63792A (US06373033-20020416-M00071.png)
SE (3) SE393111B (US06373033-20020416-M00071.png)
SU (3) SU645581A3 (US06373033-20020416-M00071.png)
YU (1) YU36953B (US06373033-20020416-M00071.png)
ZA (1) ZA734627B (US06373033-20020416-M00071.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1517973A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
US3968111A (en) * 1974-12-06 1976-07-06 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
AU526764B2 (en) * 1978-09-08 1983-01-27 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
DE3587860D1 (de) * 1984-04-09 1994-07-28 Schering Ag 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds
DE3620293A1 (de) * 1986-06-16 1987-12-17 Schering Ag 1-und/oder 2-substituierte ergolinderivate
JPH0596382U (ja) * 1992-05-28 1993-12-27 イビデン株式会社 ドアユニット

Also Published As

Publication number Publication date
ZA734627B (en) 1974-06-26
PH11229A (en) 1977-10-28
CH580626A5 (US06373033-20020416-M00071.png) 1976-10-15
CH578564A5 (US06373033-20020416-M00071.png) 1976-08-13
SE410459B (sv) 1979-10-15
DK140986B (da) 1979-12-17
BG21411A3 (US06373033-20020416-M00071.png) 1976-05-20
BG21410A3 (bg) 1976-05-20
AR210072A1 (es) 1977-06-30
GB1423065A (en) 1976-01-28
YU194573A (en) 1982-06-18
ES446789A1 (es) 1977-06-01
NL7309969A (US06373033-20020416-M00071.png) 1974-01-23
IL42730A0 (en) 1973-10-25
ES442887A1 (es) 1977-05-16
AU5792673A (en) 1975-01-16
IL42730A (en) 1976-06-30
CH581135A5 (US06373033-20020416-M00071.png) 1976-10-29
ES442885A1 (es) 1977-04-16
IL48288A0 (en) 1975-12-31
CH578563A5 (US06373033-20020416-M00071.png) 1976-08-13
DE2335750B2 (de) 1978-02-23
DE2365974A1 (de) 1977-03-24
CS208164B2 (en) 1981-08-31
JPS4985099A (US06373033-20020416-M00071.png) 1974-08-15
RO71305A (ro) 1982-03-24
SE410603B (sv) 1979-10-22
DD107690A5 (US06373033-20020416-M00071.png) 1974-08-12
IL48288A (en) 1976-06-30
IE37936L (en) 1974-01-21
JPS576431B2 (US06373033-20020416-M00071.png) 1982-02-04
SU584780A3 (ru) 1977-12-15
FR2193606A1 (US06373033-20020416-M00071.png) 1974-02-22
FR2193606B1 (US06373033-20020416-M00071.png) 1977-07-15
SU575029A3 (ru) 1977-09-30
JPS5781487A (en) 1982-05-21
SU645581A3 (ru) 1979-01-30
DK140986C (US06373033-20020416-M00071.png) 1980-07-21
SE7611467L (sv) 1976-10-15
HU167274B (US06373033-20020416-M00071.png) 1975-09-27
ES442886A1 (es) 1977-04-16
IE37936B1 (en) 1977-11-23
DE2335750C3 (de) 1978-10-19
ES417078A1 (es) 1976-05-01
AR206772A1 (es) 1976-08-23
BG22400A3 (bg) 1977-02-20
BE802531A (fr) 1974-01-21
CH580625A5 (US06373033-20020416-M00071.png) 1976-10-15
AT331425B (de) 1976-08-25
AR206887A1 (es) 1976-08-31
ATA643473A (de) 1975-11-15
SE7611466L (sv) 1976-10-15
JPS5813541B2 (ja) 1983-03-14
CA1006159A (en) 1977-03-01
DE2335750A1 (de) 1974-02-14
RO63792A (fr) 1978-12-15
YU36953B (en) 1984-08-31

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE414025B (sv) Forfarande for framstellning av fototropa flerfokala glasogonglas
SE389856B (sv) Forfarande for framstellning av alkaliperkarbonater
SE416176B (sv) Forfarande for framstellning av hogdoserade autibiotikatabletter
SE404525B (sv) Forfarande for framstellning av 4-aminometyl-cyklohexan-karboxylsyra-1
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
NO136750C (no) Fremgangsm}te for fremstilling av indanderivater
AR197040A1 (es) Procedimiento de preparacion de nuevas bifenilacetamidas
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
NO139086C (no) R fremgangsmaate for fremstilling av benzensulfonylurinstoffe
IT996099B (it) Procedimento di preparazione di amminoantrachinone
AR206786A1 (es) Procedimiento de preparacion de sulfobenzoimido-lactamas
SE386673B (sv) Forfarande for framstellning av 2-amino-2-oxazoliner
SE396377B (sv) Forfarande for framstellning av difenylmetoxietylaminer